IMARC Group’s latest research report, titled “ Non-PVC IV Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global Non-PVC IV bags market size. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The market reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the global non-PVC IV bags market to reach a value of US$ 2.47 Billion by 2027, exhibiting a CAGR of 7.70% during 2022-2027. Non-polyvinyl chloride (non-PVC) intravenous (IV) bags are those that are manufactured using polypropylene, polyethylene, copolyester-ether, or ethylene-vinyl acetate films. They are designed for packaging rehydration solutions and storing antibiotics and analgesics for hospital or veterinary usage. Moreover, non-PVC IV bags are extensively utilized in cold storage facilities as they do not affect the quality or shelf-life of the stored items.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/non-pvc-iv-bags-market/requestsample
The rising incidences of hospital-acquired infections (HAIs) are primarily driving the non-PVC IV bags market. In line with this, the increasing number of patients requiring intravenous antibiotics across healthcare facilities is further catalyzing the market growth. Moreover, the inflating adoption of single-chambered non-PVC IV bags in IV drips is also positively influencing the global market. Besides this, the elevating number of point-of-care (POC) facilities across countries and the shifting preferences towards home care setups, especially among the expanding geriatric population, are acting as significant growth-inducing factors. Furthermore, the emerging trend of using ethylene-vinyl acetate (EVA) to produce IV bags is also bolstering the market growth. Apart from this, the escalating requirement for biologically inert medical supplies and the improving healthcare infrastructures across the globe are anticipated to fuel the non-PVC IV bags market over the forecasted period.
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by material, product, content, application and end user.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Non-PVC IV Bags Market
- Strategies of major players and product offerings
Key Players Included in Global Non-PVC IV Bags Market Research Report:
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton Dickinson and Company
- Fresenius SE & Co. KGaA
- JW Life Science Co. Ltd.
- Kraton Corporation (DL Chemical Co. Ltd.)
- Medline Industries LP
- Persico S.p.a.
- Sealed Air Corporation and Sippex IV bags.
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Key Market Segmentation:
Breakup by Material:
- Ethylene Vinyl Acetate
Breakup by Product:
- Multi Chamber
- Single Chamber
Breakup by Content:
- Frozen Mixture
- Liquid Mixture
Breakup by Application:
- Targeted Drug Delivery
- Glucose Injection
- Sodium Chloride Solution
- Electrolyte Injection
- Nutrient Injection
Breakup by End User:
- Emergency Service Centers
- Ambulatory Surgical Centers
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
TOC for the Non-PVC IV Bags Market Research Report:
- Scope and Methodology
- Executive Summary
- Global Non-PVC IV Bags Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800